1 ecessary, by intestinal secretagogues and/or prokinetic agents.

2 r proton pump inhibitors in conjunction with prokinetic agents.

3  histamine 2-receptor antagonists, 5/71 (7%) prokinetic agents, 1/71 (1%) both, and 11/71 (15%) remai

4 nts (16 trials), bulking agents (13 trials), prokinetic agents (6 trials), psychotropic agents (7 tri

5                  Current treatments, such as prokinetic agents and antiemetics, offer symptomatic rel

6 olved warnings that cisapride, a widely used prokinetic agent, could cause potentially fatal arrythmi

7 d restriction, unrestricted oral intake with prokinetic agents, early ambulation, and fixed regimen e

8                                              Prokinetic agents effective in pseudoobstruction include

9                 Motilin and erythromycin are prokinetic agents that act on the same receptor in gastr

10                       Despite receiving more prokinetic agents, the full-feeding group experienced mo

11                Cisapride, a gastrointestinal prokinetic agent, was recently withdrawn from the market

12                               Itopride, is a prokinetic agent which is different and unique from the